Nicox to participate at two upcoming investor conferences   March 1, 2017 Sophia Antipolis, France Nicox S.A. (Euronext Paris: FR0013018124, COX), the international ophthalmic R&D company, today announced that members of the management team will participate in the following investor conferences in March 2017 in the United States: Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7 at 9:20 a.m. ET at the Boston Marriott Copley Place in Boston.  The presentation will be available on Nicox website (www.nicox.com) in "Presentations & Events".  Oppenheimer 27th Annual Healthcare Conference on Wednesday, March 22 at 8:35 a.m. ET at the Westin Grand Central Hotel in New York.  A live webcast of the presentation will be available on Nicox website (www.nicox.com) in "Presentations & Events". A replay of the webcast will be archived for 90 days following the date of the presentation. Members of the management team will also be available for one-on-one meetings at the conferences.
About Nicox
Nicox is an international ophthalmic R&D company utilizing innovative science to maintain vision and improve ocular health.   By leveraging its proprietary expertise in nitric oxide donation and other technologies, the Company is developing an extensive portfolio of novel therapies that target multiple ophthalmic conditions, including glaucoma.  Nicox currently has two products at the pre-approval stage with the U.S. Food and Drug Administration (FDA) and a promising pipeline including next-generation stand-alone nitric-oxide donors, with the potential to treat a range of ophthalmic indications.  Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. For more information on Nicox, its products or pipeline, please visit: www.nicox.com .
Analyst coverage
Bryan, Garnier & Co   Hugo Solvet   Paris, France Invest Securities   Martial Descoutures   Paris, France Gilbert Dupont   Damien Choplain   Paris, France Stifel    Olivia Manser   London, UK
Upcoming financial and business conferences
April 4-5  Needham's 16th Annual Healthcare Conference    New York, US April 18-19  Small Cap Event  Paris, France May 3-4  Deutsche Bank 42nd Annual Health Care Conference  Boston, US May 22-23   BioEquity Europe  Paris, France May 30  Gilbert Dupont 15th Annual Healthcare Conference   Paris, France June 19-22  2017 BIO International Convention   San Diego, US
Contacts
Nicox Gavin Spencer, Executive Vice President Corporate Development T +33 (0)4 97 24 53 00 [email protected]
Investor Relations Europe NewCap Julien Perez, Valentine Brouchot T +33 (0)1 44 71 94 94 [email protected]	Media Relations United Kingdom Jonathan Birt T +44 7860 361 746 [email protected]
United States Argot Partners Melissa Forst T +1 (212) 600-1902 [email protected]	France NewCap Nicolas Merigeau T +33 (0)1 44 71 94 98 [email protected]
	United States Argot Partners Eliza Schleifstein T +1 (917) 763-8106 [email protected]
Disclaimer
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.
Nicox S.A. Drakkar 2 Bât D, 2405 route des Dolines CS 10313,  Sophia Antipolis 06560 Valbonne,  France T +33 (0)4 97 24 53 00 F +33 (0)4 97 24 53 99